Methylphenidate
Active pharmaceutical substance formulated in Jan Aushadhi generic products for CNS, Nerve & Mental Health treatment.
🧴 Clinical Application
Take orally with water, in the morning (for extended-release) or divided morning and midday (for immediate-release), with or without meals. Do not take late in the afternoon or evening to avoid severe insomnia. Extended-release tablets must be swallowed whole without chewing or crushing.
⚠️ Side Effects
Common: Decreased appetite, weight loss, insomnia, dry mouth, nausea, abdominal pain, headache, tachycardia, palpitations. Rare/Severe: Boxed warning: High potential for abuse and dependence; sudden cardiac death in pre-existing cardiac defects, severe hypertension, priapism, peripheral vasculopathy (Raynaud's), and growth suppression in children.
🛡️ Safety Warnings
Black box warning: High abuse potential and dependence. Schedule X controlled substance in India; strict prescription records required. Contraindicated in severe anxiety/agitation, glaucoma, tics/Tourette's syndrome, and concurrent MAOIs. Monitor height, weight, blood pressure, and heart rate regularly in children.
Jan Aushadhi Products containing Methylphenidate
Found 4 generic formulation(s) containing this active ingredient.
Methylphenidate Tablet 10Mg
Methylphenidate Hydrochloride is a central nervous system stimulant on the WHO Model List of Essential Medicines. It acts by blocking the presynaptic dopamine transporter (DAT) and norepinephrine transporter (NET), substantially inhibiting reuptake and boosting synaptic catecholamine availability in the prefrontal cortex, enhancing sustained attention, impulse inhibition, and executive control. Indicated for Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy.
Methylphenidate Tablet 18Mg
Methylphenidate Hydrochloride is a central nervous system stimulant on the WHO Model List of Essential Medicines. It acts by blocking the presynaptic dopamine transporter (DAT) and norepinephrine transporter (NET), substantially inhibiting reuptake and boosting synaptic catecholamine availability in the prefrontal cortex, enhancing sustained attention, impulse inhibition, and executive control. Indicated for Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy.
Methylphenidate Tablet 20Mg
Methylphenidate Hydrochloride is a central nervous system stimulant on the WHO Model List of Essential Medicines. It acts by blocking the presynaptic dopamine transporter (DAT) and norepinephrine transporter (NET), substantially inhibiting reuptake and boosting synaptic catecholamine availability in the prefrontal cortex, enhancing sustained attention, impulse inhibition, and executive control. Indicated for Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy.
Methylphenidate Tablet 5Mg
Methylphenidate Hydrochloride is a central nervous system stimulant on the WHO Model List of Essential Medicines. It acts by blocking the presynaptic dopamine transporter (DAT) and norepinephrine transporter (NET), substantially inhibiting reuptake and boosting synaptic catecholamine availability in the prefrontal cortex, enhancing sustained attention, impulse inhibition, and executive control. Indicated for Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Methylphenidate.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Methylphenidate Tablet 10Mg | 10's | Under Process | N/A | N/A | N/A |
| Methylphenidate Tablet 18Mg | 10's | Under Process | N/A | N/A | N/A |
| Methylphenidate Tablet 20Mg | 10's | Under Process | N/A | N/A | N/A |
| Methylphenidate Tablet 5Mg | 10's | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Methylphenidate generics.